the oxford vaccine group working on collective responsibility for infectious disease in london max lawson is head of inequality policy at oxfam international very well welcome to the program thanks for joining us here on inside story i'd like to begin with you samantha america as a read saying is about to receive control of a patient of basically the technology which is at the heart of several coronavirus vaccines can you explain that for us and what it might be so i think we have already lost some opportunities to apply pressure on pharma companies to open license and we know that already but there there is a chance that the governments like the u.s. can now apply pressure to have more transfer of technology through their ownership things like this with pate. so this patent is i guess millette killer engineering this is this is being described as the last best chance that we have the equitable access what do you think thomas pogge do you think this is the world's last best chance do you think that the world will take it will the us use this opportunity to pressure the drug makers now tha